features of acute chikungunya virus infection are fever of sudden onset and severe, often debilitating polyarthralgia. Rash and gastrointestinal symptoms are also frequent findings [10] .
Since June 2004, when the first documented outbreak occurred in Lamu, Kenya, an epidemic of chikungunya virus infection has progressively spread to different countries in the Indian Ocean region [11] . On Reunion Island, where chikungunya virus infection had never been previously reported, the first cases were reported in March 2005, and their number significantly increased in December 2005 and after [12] . From March 2005 through April 2006, the surveillance system estimated that 244,000 cases of chikungunya virus infection occurred in a general population of 766,000, with an overall attack rate of 35% [12] . During the Reunion Island epidemic, unusually severe forms of the disease were recorded [12] , and several cases of maternal-neonatal transmission were observed for the first time [13] . Throughout the Indian Ocean epidemic, imported cases of chikungunya virus infection in travelers returning from affected areas were reported in several European and American countries [14] [15] [16] [17] . In August 2007, autochthonous cases of chikungunya virus infection were detected in northeastern Italy [18] , the first time that this disease occurred in a temperate country. The presence of 1 of the competent vectors, A. albopictus, in a growing number of countries and the always-increasing number of international travelers raise major concerns about the introduction of chikungunya virus into other previously unexposed areas.
Although the clinical features of acute chikungunya virus infection have already been described in several reports [1, 10, 19] , little is known about the long-term outcomes of the disease. Persistent arthralgia was already observed by Robinson [1] in the first description of chikungunya virus infection, but the only study that evaluated long-term persistent arthralgia in a substantial number of patients was by Brighton et al. [20] in 1983; this study examined a group of South African patients 3 years after the acute phase of illness. In the report by Brighton et al. [20] , in which almost one-half of the patients were !17 years of age, most patients were fully recovered within 1 year. In our experience, the persistence of arthralgia in adult patients from Reunion Island appeared to be more significant than in report by Brighton et al. [20] which incited us to perform our study. Our study's objectives were to evaluate the prevalence and nature of and risk factors associated with persistent arthralgia in a population previously affected by acute chikungunya virus infection.
PATIENTS AND METHODS
Reunion Island is a French overseas territory located in the southwestern part of the Indian Ocean, east of Madagascar. The medical system and accessibility to medical care are the same as in France. The Groupe Hospitalier Sud Reunion is a tertiary nonteaching institution with a referral population of ∼350,000 individuals.
Patients. We studied a cohort of patients with laboratoryconfirmed acute chikungunya virus infection who were referred to our institution from March 2005 through April 2006. For this cohort, the following inclusion criteria had to be met: age у16 years, clinical presentation consistent with chikungunya virus infection (e.g., abrupt onset of fever and/or polyarthralgia), onset of symptoms within 10 days preceding the referral, and laboratory confirmation of chikungunya virus infection by positive RT-PCR results, paired serum sample seroconversion, or positive IgM serologic test results. For all of the patients, data on clinical features and laboratory findings during the acute phase of illness were available. All of the enrolled patients were contacted by telephone (when the telephone number was available in the medical file), several times if necessary, by a member of the Centre d'Investigation Clinique and invited to participate to the study. All the patients consented to their involvement in the study.
Assessments. Patients were assessed in our department (Service de Pneumologie et Maladies Infectieuses, Groupe Hospitalier Sud Reunion; Saint Pierre, La Réunion, France) from August 2007 through October 2007 and were assessed a mean (‫ע‬SD) of months after acute illness. Three physi-18.7 ‫ע‬ 2.1 cians interrogated the patients using a standard form and performed the physical examination. The standard form was used for abstracting previous history of arthralgia and the nature of current symptoms (i.e., their frequency, localization, and impact on everyday life).
We defined persistent arthralgia as an intermittent or continuous joint pain that, in the judgment of the patient, was related to chikungunya virus infection. If the patient was already affected by joint pain before acute chikungunya virus infection, arthralgia was considered to be secondary to chikungunya virus infection if it differed in intensity or localization from the prior symptoms. Arthralgia was considered to be continuous when joint pain was present every day, even if it fluctuated in severity.
For the patients who presented with intermittent arthralgia, we determined the localization of the joint pain during the most recent episode of arthralgia. Relapse was defined as a bout of joint pain that lasted 11 day with an intensity that was equivalent to or greater than that associated with acute illness and that occurred 11 month after acute chikungunya virus infection after a symptom-free period of 11 month. The physical examination was focused on articular signs; all of the joints were inspected for the presence of swelling and checked for pain elicited by passive movement. All the patients were tested for the presence of IgM antibodies to chikungunya virus in serum samples obtained on the day of the assessment. Chikungunya virus-specific IgM antibody was detected by IgM-capture ELISA using a chikungunya virus antigen produced by the Centre National de Rèférence des Arbovirus (Lyon, France) [21] .
Statistical analysis. Results are expressed as mean value (‫ע‬SD) and as number (percentage) of patients. The MannWhitney U test was used to calculate differences in laboratory findings and continuous variables between patients with persistent arthralgia and patients who had experienced recovery. Analysis was conducted using the x 2 test, with use of Fisher's exact test, as needed, for comparison of categorical variables between patients with persistent arthralgia and patients who had experienced recovery.
was considered to be statis-P ! .05 tically significant.
RESULTS
A total of 202 patients who fulfilled the inclusion criteria were identified. The mean age (‫ע‬SD) of the patients was 57.7 ‫ע‬ years; the male-to-female ratio was 1.1:1.0. For 60 patients 19.9 (29.7%), the telephone number was unavailable or incorrect. One hundred forty-two households were contacted by telephone. Sixteen (7.9%) of 202 patients died in the months after acute illness. The mean age (‫ע‬SD) of the patients who died was years; the male-to-female ratio of the patients 74.6 ‫ע‬ 11.2 who died was 1.3:1.0. In 8 patients, it was possible to assess the cause of death; in each case, death was secondary to an aggravation of an underlying disease. Of the 126 patients who were contacted by telephone, 36 (28.6%) did not agree to participate or were unable to participate in the study. Two patients were secondarily excluded, because they were not tested for IgM antibodies.
Eighty-eight patients were included in this study. The mean age (‫ע‬SD) age was years; the male-female ratio was 58.3 ‫ע‬ 18 1.1:1.0. At least 1 underlying illness was present in 63 patients (71.6%); the most frequent illnesses were hypertension and diabetes mellitus. A history of chronic arthralgia preceding the chikungunya virus infection was reported by 39 patients (44.3%). The 2 most frequently reported causes of arthralgia were osteoarthritis (26 patients; 66.6%) and gout (7 patients; 17.9%).
Fifty-eight patients (65.9%) had been hospitalized with acute chikungunya virus infection. Among the patients included in the study, the laboratory diagnosis of acute chikungunya virus infection was made by positive RT-PCR results in 31 patients, seroconversion in 7 patients, and positive IgM test results in 50 patients. The mean delay (‫ע‬SD) between onset of symptoms and IgM positivity was days. At the time of assess-10.1 ‫ע‬ 6.5 ment, test results were still positive for IgM antibodies specific to chikungunya virus in 35 patients (39.7%).
At the time of assessment, 32 patients (36.4%) considered themselves to have recovered from arthralgia related to chikungunya virus infection. For these patients, the mean duration of chikungunya virus-related arthralgia (‫ע‬SD) was 2.9 ‫ע‬ 2.4 months. In this group, 10 patients, all of whom had already been affected by chronic arthralgia before chikungunya virus infection, were still experiencing joint pain at the time of assessment that they attributed to the preexisting illness. Relapse of joint pain was reported by 1 patient.
At the time of assessment, 56 patients (63.8%) reported persistent arthralgia related to chikungunya virus infection. The nature and localizations of arthralgia are summarized in tables 1 and 2. For 31 patients (55.4%), joint pain was continuous. Arthralgia was polyarticular in all patients. Discomfort in performing the activities of everyday life (e.g., walking, eating, and getting dressed) was identified in 26 patients (46.4%). Relapses were reported by 12 patients (21%). Joint swelling, which was mainly observed in the ankles, was noted in 9 patients (16.1%). Taking self-reported pain into consideration, metacarpophalangeal joints (in 57.1% of patients) and knees (57.1%) were In the group of patients who experienced recovery, thrombocytopenia and elevated liver enzyme levels were significantly more common on days 0-1 and days 3-5. Comparison of other laboratory findings on days 3-5 are not reported in table 3, because they did not reveal any statistically significant difference.
DISCUSSION
The recent Indian Ocean epidemic and the Italian outbreak in 2007 [18] have drawn new attention to chikungunya virus infection, a long-neglected disease. Still, many aspects of this disease have been poorly studied. Although it is already well established that severe arthralgia is one of the hallmark clinical features of acute chikungunya virus infection [1, 10, 19, 22, 23] , little is known about the long-term persistence of this symptom.
In our study, 56 (63.8%) of the enrolled patients were still presenting with joint pain ∼18 months after acute chikungunya virus infection that, in their judgment, was secondary to the chikungunya virus infection. Persistent arthralgia (always polyarticular) was continuous for 31 (55.4%) of these patients, and almost one-half of them reported some difficulties in performing activities of daily life.
To our knowledge, only 1 other report in the international literature has studied long-term, persistent arthralgia in a large group of patients with laboratory-confirmed chikungunya virus infection [20] . In this study, performed in South Africa in 1980 by Brighton et al. [20] , in which several patients were questioned only by telephone, 94 (87.9%) of 107 patients were free of symptoms 3-5 years after acute infection. The discordance between this study [20] , which reported a much higher proportion of patients who experienced recovery, and our study can be easily explained. In the study by Brighton et al. [20] , patients were assessed later than they were in our study, and almost one-half of the patients were !17 years of age; it is known that arthralgia has a milder course in children [24, 25] . In a more recent French report with a shorter-term follow-up, Simon et al. [23] studied a cohort of 47 travelers (46 adults and 1 infant; mean age, 45.1 years) returning from the Indian Ocean islands. In this series, in which 11 patients required hospitalization, 48% of patients were still symptomatic 6 months after disease onset.
The other objective of our study was to identify the possible predictors of persistent arthralgia; therefore, we compared several risk factors in the group of patients who experienced recovery and the group of patients who still had arthralgia. A lower platelet count and an elevation of liver enzyme levels during acute chikungunya virus infection in patients who experienced recovery and a higher number of relapses among the patients with persistent arthralgia were the only significant differences between the 2 groups. The laboratory results could suggest that a more severe acute illness can predict, paradoxically, a favorable outcome, but the clinical significance of this finding is uncertain.
Relapse of severe joint pain was reported by 12 (21.4%) of the patients, confirming the fluctuating nature of arthralgia associated with chikungunya virus infection. Relapses of arthralgia have already been reported by other authors [23, 26] as being a common feature in the months after acute chikungunya virus infection; however, in these previous studies, no definition of relapse was given. We have tried to eliminate this bias in our study to obtain a more accurate estimation of the finding.
Preexisting joint pain, which has been significantly associated with a worse evolution of Ross River virus infection [27] , was more frequent among patients with persistent arthralgia, although the difference was not statistically significant.
A previous seroprevalence study [21] found that 55.5% of patients were IgM positive 13-18 months after acute chikungunya virus infection; this study shows an unusual persistence of specific IgM antibodies, with 25 (39.7%) of 45 patients testing IgM positive. It is noteworthy that, for infection due to West Nile virus [28] , which is another arborvirus associated with long-term sequelae, the same phenomenon has been observed. The pathogenesis of arthropathy in chikungunya virus infection has not yet been clearly understood, but it is likely that, as with Ross River virus infection [29] , the immune response plays an essential role. Therefore, it was particularly interesting to check whether there was any statistically significant association between the presence of IgM antibodies and persistent arthralgia. This association has been ruled out in our study, in which the prevalence of positive IgM test results was even higher among the patients who experienced recovery.
Our report has several limitations. We relied on the voluntary participation of individuals from a retrospective cohort, and one-quarter of the patients who were contacted did not participate in the study. Therefore, the possibility of selection bias, particularly in favor of patients with more-severe illness, has to be considered. The enrolled individuals represent a group of patients who presented with a more-severe form of chikungunya virus infection, who often need hospitalization and cannot be considered to be representative of the general population. In addition, our cohort was largely composed of middle-aged and elderly people, which partially reflects the estimate of the surveillance system on Reunion Island, which found a predominance of adults in the affected population [12] .
The same age distribution was reported in the recent Italian outbreak, in which the median age of the patients affected by chikungunya virus infection was 61 years [18] . Another bias of this study is related to the subjectivity of the symptoms. Although we tried to reduce this bias by directly questioning the patients and performing physical examinations, it was clearly difficult to objectively assess the relationship between persistent arthralgia and chikungunya virus infection. Apart from elicited pain, findings on physical examination were scarce, and in the few patients who presented with swollen joints (usually the ankles), this sign could be attributed to other underlying illnesses. The discordance between the localization of self-reported pain and the findings on physical examination can be seen as a consequence of the doubtful reliability of selfreported symptoms; however, we have to remember that many patients reported intermittent pain and, therefore, were symptom free the day of the assessment; in addition, another characteristic of chikungunya virus-related arthralgia is its migratory nature.
A further issue was the fact that 29 of 56 patients with persistent arthralgia reported a prior history of joint symptoms, which made establishing the real cause of joint pain difficult. For this reason, we used a definition of persistent arthralgia that was designed to reduce this bias, stressing how the present pain was not comparable to previous pain.
The fact that, among the patients who experienced recovery, 10 patients still had arthralgia but did not attribute their joint pain to chikungunya virus infection (because the pain was similar to that which they felt before the infection) seems to indicate that patients can differentiate the nature of their pain. Even if we had not considered patients with previous arthralgia, the proportion of patients still affected by persistent arthralgia (30.7%) would have been noteworthy. This difficulty in relating a persistent joint pain to a viral arthritis has already been reported [27, [30] [31] [32] for Ross River virus infection, for which several surveys regarding the evolution of rheumatic manifestations have produced conflicting data.
We could have obtained more-reliable data by comparing our group of patients with a control group of uninfected patients. However, several issues made this kind of study difficult to perform on Reunion Island. As previously shown by a seroprevalence study [33] , 38% of the general population on Reunion Island were infected by chikungunya virus during the 2005-2006 outbreak. The proportion of infected patients was even higher in the southern part of the island, where our institution is located, and a seroprevalence 150% was reported among the elderly patients, which made recruitment of an uninfected control group problematic.
The real burden of chikungunya virus infection-a disease that, for a long time, was considered to be benign-has yet to be precisely estimated. At the acute stage of the illness, lost productivity is a frequent concern; a study conducted among hospital staff on Reunion Island found that 76.8% of affected patients took time off from work [26] . In another report [34] , in a population of military policemen, quality of life was still severely impaired several weeks after acute infection. Even though it has limitations, our study shows how persistent arthralgia, often continuous and debilitating, is a frequent concern among patients with chikungunya virus infection. This is especially the case among middle-aged and elderly patients, one of the populations most affected in the recent epidemics. Further consultations and hospitalizations may be needed because of the pain and disability associated with chikungunya virus infection; this should be included in the assessment of the overall economic impact of chikungunya virus infection, a disease which, considering the globalization of one of its competent vectors, A. albopictus, is at risk of becoming a major public health threat. To have a more accurate estimate of persistent arthralgia related to chikungunya virus infection in the general population, a prospective, case-control study that involves a larger number of patients and includes patients with milder forms of the disease at the acute stage is needed.
